Amphastar Pharmaceuticals Inc (NAS:AMPH)

$ 46.09 -7.31 (-13.69%) Market Cap: 2.26 Bil Enterprise Value: 3.02 Bil PE Ratio: 14.73 PB Ratio: 3.10 GF Score: 88/100

Q3 2024 Amphastar Pharmaceuticals Inc Earnings Call Transcript
1 day ago

$53.38 (+3.53%)

Earnings
Q2 2024 Amphastar Pharmaceuticals Inc Earnings Call Transcript
Aug 07, 2024

$38.89 (-1.29%)

Earnings
Q1 2024 Amphastar Pharmaceuticals Inc Earnings Call Transcript
May 08, 2024

$42.21 (-1.31%)

Earnings
Q4 2023 Amphastar Pharmaceuticals Inc Earnings Call Transcript
Feb 28, 2024

$54.74 (-1.26%)

Earnings
Amphastar Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
Jan 10, 2024
Q3 2023 Amphastar Pharmaceuticals Inc Earnings Call Transcript
Nov 08, 2023

$45.42 (-1.28%)

Earnings
Q2 2023 Amphastar Pharmaceuticals Inc Earnings Call Transcript
Aug 08, 2023

$65 (+3.04%)

Earnings
Amphastar Pharmaceuticals Inc at Jefferies Healthcare Conference Transcript
Jun 08, 2023
Q1 2023 Amphastar Pharmaceuticals Inc Earnings Call Transcript
May 09, 2023

$36.44 (+0.05%)

Earnings
Amphastar Pharmaceuticals Inc Business Update Call Transcript
Apr 24, 2023
Amphastar Pharmaceuticals Inc at Needham Healthcare Conference (Virtual) Transcript
Apr 19, 2023
Q4 2022 Amphastar Pharmaceuticals Inc Earnings Call Transcript
Feb 28, 2023

$31.86 (-1.85%)

Earnings
Q3 2022 Amphastar Pharmaceuticals Inc Earnings Call Transcript
Nov 07, 2022

$30.1 (+1.14%)

Earnings
Q2 2022 Amphastar Pharmaceuticals Inc Earnings Call Transcript
Aug 08, 2022

$37.75 (+2.69%)

Earnings
Q1 2022 Amphastar Pharmaceuticals Inc Earnings Call Transcript
May 09, 2022

$31.76 (-2.90%)

Earnings
Q4 2021 Amphastar Pharmaceuticals Inc Earnings Call Transcript
Mar 10, 2022

$30.47 (+1.23%)

Earnings
Q3 2021 Amphastar Pharmaceuticals Inc Earnings Call Transcript
Nov 08, 2021

$19.95 (-0.65%)

Earnings
Q2 2021 Amphastar Pharmaceuticals Inc Earnings Call Transcript
Aug 09, 2021

$20.08 (-1.13%)

Earnings
Amphastar Pharmaceuticals Inc at Raymond James Human Health Innovation Conference (Virtual) Transcript
Jun 22, 2021
Amphastar Pharmaceuticals Inc Annual Shareholders Meeting Transcript
Jun 07, 2021
Q1 2021 Amphastar Pharmaceuticals Inc Earnings Call Transcript
May 06, 2021

$18.05 (+0.56%)

Earnings
Q4 2020 Amphastar Pharmaceuticals Inc Earnings Call Transcript
Mar 15, 2021

$19.15 (-1.08%)

Earnings
Q3 2020 Amphastar Pharmaceuticals Inc Earnings Call Transcript
Nov 06, 2020

$19.2 (-6.93%)

Earnings
Q2 2020 Amphastar Pharmaceuticals Inc Earnings Call Transcript
Aug 06, 2020

$20.27 (-3.89%)

Earnings
Amphastar Pharmaceuticals Inc Annual Shareholders Meeting Transcript
Jun 08, 2020
Q1 2020 Amphastar Pharmaceuticals Inc Earnings Call Transcript
May 07, 2020

$17.6 (+1.56%)

Earnings
Amphastar Pharmaceuticals Inc at Needham Healthcare Conference Transcript
Apr 15, 2020
Q4 2019 Amphastar Pharmaceuticals Inc Earnings Call Transcript
Mar 12, 2020

$13.87 (-9.35%)

Earnings
Q3 2019 Amphastar Pharmaceuticals Inc Earnings Call Transcript
Nov 07, 2019

$19.12 (+0.21%)

Earnings
Q2 2019 Amphastar Pharmaceuticals Inc Earnings Call Transcript
Aug 07, 2019

$19.69 (+0.61%)

Earnings
Amphastar Pharmaceuticals Inc at Bank of America Merrill Lynch Health Care Conference Transcript
May 15, 2019
Q1 2019 Amphastar Pharmaceuticals Inc Earnings Call Transcript
May 09, 2019

$22.63 (+0.53%)

Earnings
Q4 2018 Amphastar Pharmaceuticals Inc Earnings Call Transcript
Mar 12, 2019

$24.17 (+1.90%)

Earnings

Amphastar Pharmaceuticals Inc Annual Shareholders Meeting Transcript

Jun 08, 2020 / 06:00PM GMT

Release Date Price: $20.08 (+2.87%)

Transcript

Operator

Welcome to the 2020 Annual Meeting for Amphastar Pharmaceuticals. Our host for today's call is Dr. Mary Luo, Chairman, COO and Chief Scientist. (Operator Instructions) I will now turn the call over to your host, Dr. Luo, you may begin.

Ziping Luo

Amphastar Pharmaceuticals, Inc. - Chairman of the Board, Chief Scientist & COO

Good morning, ladies and gentlemen. I am Mary Luo, Chairman, Chief Operating Officer and Chief Scientist of Amphastar Pharmaceuticals. And it is a pleasure to welcome you to Amphastar Pharmaceuticals' Annual Meeting of Stockholders. We especially welcome you to this virtual meeting of Stockholders and hope that you and your families are well at this unique time in our nation's history.

As provided in the company's bylaws, I will act as Chairperson of this meeting. I have asked that Jacob Liawatidewi, our Corporate Secretary, to act as secretary of this meeting and record the minutes.

Before proceeding further, let me introduce the other directors and director nominees of the company who are with us today: Jack

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.